Zentalis Pharmaceuticals
ZNTL
ZNTL
142 hedge funds and large institutions have $195M invested in Zentalis Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 57 increasing their positions, 31 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
9.41% less ownership
Funds ownership: 99.8% → 90.39% (-9.4%)
25% less capital invested
Capital invested by funds: $261M → $195M (-$66M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
142
Holding in Top 10
1
Calls
$229K
Puts
$222K
Top Buyers
| 1 | +$3.18M | |
| 2 | +$2.43M | |
| 3 | +$2.43M | |
| 4 |
AC
Almitas Capital
Santa Monica,
California
|
+$2.02M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.51M |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$12.3M | |
| 3 | -$4.06M | |
| 4 |
DC
Decheng Capital
Menlo Park,
California
|
-$2.33M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.7M |